O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-12.53%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$9.47B
AUM Growth
+$9.47B
(-14%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
41.65%
Holding
145
New
14
Increased
43
Reduced
27
Closed
6
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$95.1M |
| 2 |
Corvus Pharmaceuticals
CRVS
|
$76.2M |
| 3 |
UnitedHealth
UNH
|
$74M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$72.1M |
| 5 |
Eli Lilly
LLY
|
$66.8M |
Top Sells
| 1 |
HNT
HEALTH NET INC
HNT
|
$205M |
| 2 |
Viatris
VTRS
|
$143M |
| 3 |
AFFX
AFFYMETRIX INC
AFFX
|
$75.8M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$56.3M |
| 5 |
Bristol-Myers Squibb
BMY
|
$49.2M |
Sector Composition
| 1 | Healthcare | 90.2% |
| 2 | Financials | 0.22% |
| 3 | Technology | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTX
126
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $1.13M | 0.01% | 1,073,000 | – | – |
|
|
CGNT
127
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.09M | 0.01% | 990,745 | – | – |
|
|
BLRX
128
BioLineRX
BLRX
$16.2M
| $1.06M | 0.01% | 1,038,600 | – | – |
|
|
QLTI
129
DELISTED
QLT Inc
QLTI
| $995K | 0.01% | 500,000 | – | – |
|
|
AMRN
130
Amarin Corp
AMRN
$311M
| $536K | 0.01% | 350,000 | – | – |
|
131
MannKind Corp
MNKD
$1.41B
| – | – | 0 | – | – |
|
132
Molina Healthcare
MOH
$9.8B
| – | – | -568,850 | Closed | -$34.2M |
|
133
Ocular Therapeutix
OCUL
$2.12B
| – | – | -155,000 | Closed | -$1.45M |
|
|
KDNY
134
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – | -60,000 | Closed | -$1.69M |
|
|
VTAE
135
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| – | – | -487,400 | Closed | -$8.82M |
|
|
AFFX
136
DELISTED
AFFYMETRIX INC
AFFX
| – | – | -7,511,000 | Closed | -$75.8M |
|
|
HNT
137
DELISTED
HEALTH NET INC
HNT
| – | – | -2,988,800 | Closed | -$205M |
|